9-Nitrocamptothecin
-
9-Nitrocamptothecin
structure -
-
CAS No:
91421-42-0
-
Formula:
C20H15N3O6
-
Chemical Name:
9-Nitrocamptothecin
-
Synonyms:
1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-10-nitro-,(4S)-;1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-10-nitro-,(S)-;(4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;9-Nitrocamptothecin;9-Nitro-20(S)-camptothecin;RFS 2000;Rubitecan;Orathecin;2050741-77-8
- Categories:
-
CAS No:
Description
Rubitecan (RFS 2000), a camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3].
Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin. It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and a prodrug. It is a pyranoindolizinoquinoline, a C-nitro compound, a semisynthetic derivative, a tertiary alcohol and a delta-lactone.|Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks. (NCI04)
Characteristics
127.24000
1.38
Yellow amorphous powder
1.6±0.1 g/cm3
182-186 °C
816.3±65.0 °C at 760 mmHg
106℃
1.762
room temp
3.53E-28mmHg at 25°C
D23 +27° (c = 0.2 in CH3OH-CHCl3, 1:4)
Drug Information
Investigated for use/treatment in pancreatic cancer, leukemia (unspecified), melanoma, ovarian cancer, and cancer/tumors (unspecified).
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)|Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)
Rubitecan prevents DNA from unwinding during replication via DNA topoisomerase 1, therefore interfering with tumor growth.
9-nitro-20(S)-camptothecin
9-Nitrocamptothecin Use and Manufacturing
Semisynthetic camptothecin which inhibits DNA topoisomerase I. Prodrug of 9-aminocamptothecin. Antineoplastic
Human drugs -> Rare disease (orphan)
Computed Properties
Molecular Weight:393.3
XLogP3:0.8
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:1
Exact Mass:393.09608521
Monoisotopic Mass:393.09608521
Topological Polar Surface Area:126
Heavy Atom Count:29
Complexity:861
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 9-Nitrocamptothecin
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of Chemical Pesticides,Food Additives,Agrochemicals,Active Pharm Ingredients,Flavors and Fragrances,Chemical Catalyst,Chemical Materials,Chem&Pharm Intermediates,Organic Intermediates,Feed Additive
Learn More Other Chemicals
-
9-Nitrocamptothecin
86639-62-5
-
[3,4-diacetyloxy-5-(4-amino-2-oxo-1,3,5-triazin-1-yl)oxolan-2-yl]methyl acetate
10302-78-0
-
Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride)
873310-31-7
-
(3S)-4-Chloro-1,3-butanediol Formula
139013-68-6
-
5-chloro-N-(4-nitrophenyl)pentanamide Formula
1039914-85-6
-
6-AMino-5-azacytidine Formula
105331-00-8
-
Amoxicillin Related Compound D (50 mg) ((4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, monosodium salt) Structure
68728-47-2
-
4-AMINO-6-METHYL-1,3,5-TRIAZIN-2-OL Structure
16352-06-0
-
What is Littorine
21956-47-8
-
What is 10βH-Guai-11(13)-en-12-oic acid,3α,4:10,14-diepoxy-2β,5,6α,8β-tetrahydroxy-,12,6-lactone,8-(2-methylcrotonate),(Z)-
20071-54-9